enow.com Web Search

  1. Ads

    related to: new drugs for schizophrenia

Search results

  1. Results from the WOW.Com Content Network
  2. FDA approves 1st new drug for schizophrenia in more ... - AOL

    www.aol.com/fda-approves-1st-drug-schizophrenia...

    The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers Squibb ...

  3. This FDA-approved drug promises a new way to treat schizophrenia

    www.aol.com/fda-approved-drug-promises-way...

    People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug.. Studies ...

  4. FDA Approves the First New Schizophrenia Drug in Decades - AOL

    www.aol.com/fda-approves-first-schizophrenia...

    N o new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

  5. List of antipsychotics - Wikipedia

    en.wikipedia.org/wiki/List_of_antipsychotics

    Antipsychotics by class Generic name Brand names Chemical class ATC code Typical antipsychotics; Acepromazine: Atravet, Acezine: phenothiazine: N05AA04

  6. Xanomeline/trospium chloride - Wikipedia

    en.wikipedia.org/wiki/Xanomeline/trospium_chloride

    The effectiveness of xanomeline/trospium chloride for the treatment of schizophrenia in adults was evaluated in two studies with identical designs. [2] Study 1 (NCT04659161) and study 2 (NCT04738123) were 5-week, randomized, double-blind, placebo-controlled, multi-center studies in adults with a diagnosis of schizophrenia according to DSM-5 ...

  7. Ulotaront - Wikipedia

    en.wikipedia.org/wiki/Ulotaront

    The Brief Negative Symptom Scale (BNSS) has been used to assess the effect of Ulotaront on the negative symptoms of schizophrenia. [16] In July 2023, the pharmaceutical company behind the drug announced that the drug had failed to outperform placebo in the treatment of acutely psychotic patients with schizophrenia, as measured by the PANSS. [17]

  1. Ads

    related to: new drugs for schizophrenia